The patent will now be validated in several EU countries, which could potentially allow IP protection for its allogeneic bone cell
therapy platform until 2029.
Feb 5, 2015 (SeeNews) - Belgian bone cell
therapy company Bone Therapeutics said it had raised EUR 32.
The team from the University of Glasgow's Colleges of Science and Engineering and Medical, Veterinary and Life Sciences have found a reliable method to encourage bone cell
growth around a new type of implant.
While hydroxyapatite encourages bone cell
ingrowth, when it is porous like natural bone, it is mechanically weak.
Different types of bone cell
either build up bone or break it down.
Other topics of the 15 papers include the bone-oral implant interface, the diabetic gastrointestinal tract, bone cell
adhesion onto orthopedic implants, external pelvic fixation during lumbar muscle resistance exercise, and pressure sensors for running shoe fit measurement.
Michaels Hospital in Toronto, Canada suggest that a natural tomato complex may not only help prevent bone loss but may actually promote new bone cell
loss is measured on a scale ranging from mild (Osteopenia) to more severe (Osteoporosis) that indicate the risk of a fracture.
Bone Therapeutics, a Belgium-based bone cell
therapy company focusing on orthopaedics and bone disease, has appointed Miguel Forte to the position of chief medical officer (CMO), it was reported yesterday.
Jan 22, 2015 (SeeNews) - Belgian bone cell
therapy company Bone Therapeutics aims to raise between EUR 25 million (USD 29m) and EUR 33 million with an initial public offering (IPO) in Brussels and Paris, the firm's prospectus showed Wednesday.